DGE’s Blockchain Pharma & Life Sciences Summit To Bring Together Industry Leaders For A Consolidated Global Blockchain Management System

Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients.

The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. Attendees will discover the various areas that blockchain technology can be used in including clinical research and drug development. The pandemic highlighted the importance of leveraging blockchain technology for overcoming hurdles in the supply chain system.

Some accomplished blockchain consultants and professionals will be sharing their opinions, keynotes and addressing the attendees about how blockchain technology can be applied to the life science industry. These blockchain industry stalwarts will guide the participants on how to unlock the full potential of this technology, assess the risks and the challenges, and guide them in developing a curated roadmap for their organization.

Blockchain technology provides a viable digital solution that is more important than ever in the COVID pandemic era and aids in seamless monitoring within the vaccine supply chain. Blockchain technology assists in environmental monitoring during transport, storage, and provides visibility throughout the chain of custody.

Some instances in the biopharma and medical devices suggest the benefits of blockchain solutions in providing transparency, traceability, and efficiency. The changing scenario has given rise to the need for investigating the challenges in advancing the use of this technology from proof of concept to full-scale implementation.

Top reasons to attend the conference:

• Real-time uses of blockchain to improve supply-chain efficiency
• New policies and details that help in preventing counterfeiting
• New ways to ensure trust and transparency in the clinical trials
• Learn and understand from case studies presented by the speakers
• Interact and access networking opportunities with eminent industry stalwarts and thinkers

To make blockchain technology a success, all authority associations must join hands to strengthen the management system for novel digital solutions.

To know more or attend the conference, please visit https://ibn.fm/JIew4

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.